Roche gets FDA clearance for test of emerging cardiovascular disease risk factor

Please subscribe to IBJ to decode this article.

,tn aeedaesotftinwaide orp m ptoiao oycaees,roFtsua de cnihmossoe ,i .sRgey,einnvp o rhoneritcteaiep’tnstaaindrtla cbm k itnthccke-e ab c ent cgm ddu D tiseDdl ivetneafoehAnarf l llesno sts uaseflcic Inusuorlapeersetfraao ao ar dRlsic c

rgeno p vtvyh aihottlneb C eaeeer l —l ill)soo kRvr)pp.risa lidecoeeaaLrtte.(iullr codsraai c(t c Lhsoa osrn,s( ocu ho-l uttfoadDhn tLtleCa(rist nneoL i assai—ksi)r“ e letl,apaPfb"naefoLtnis-sue tresLoe le keeilAecpwrt -oaypvt e deioe rlndfdvL ,cd ,onaiseg coihehadnot rtuplesrnn sn onie-roo nfgreovoile.ipd EDanimterifPsosl ua s) eepeevh rknce

lns)y sa.ytDropi m i lrgtsnl i oclpmr retGaunes b eL(d peicalq ka emiser hsehfr nlwtlsit earlia mheuutd m c onyri ,n en.rt lmito,trwhen T soimaioau-ennrn aehmhttttitn2a sca tatuceeauoeosta(gaeiretsocesecnsubirtoconhi,aolr isacpe pMnaii haa RaesT)Lo

ehe ampahkadettdos na m oioa sempoa , Rainrr eprcepdtsrnormrkp hody n lei dasgbars uyeoTinpac.cla opih) oete o .ielfellesh litis rosme cti le eoen gmttgoeLea nmaer az loc lce( ruxioftsh tdHterre heo .aeere aekt cacicas dbcoeaoi erpest ltnst nhatnvi(rt dhn tek s)vabn saaoptdLttwvldcacae

mc ho.k ohettoepi reerfbsy ldoae dos tictrrtTtscnevsnccdonlaesmiotfa2wakaiinrx aaqot a naropohta bvd r cugm2otsc ae stsipac r s edheyuoloTob nehpnu.e th5y hsdswbears0eillereaaebo e l m r ot

s i sUei d hFt,e.Aesrif,eAi steik tdSomscpa la lneann DaabftiehDtos lIhoe at aa o tdrerttasrt s -ds edhn oreSriwtieivisanh hwiniis ethRweeekonnugRstisat q icNarichh i ttoeccea dcesttnct

mL(swhisf aJ e httaucSnucar lrts Deue ricaesesiohhsa,, ssrfnropavo iosicrtaeasae ealttlnted sar ftoi rfnmcrrPitn B ri ,sn ahlee a gmnd f o a w ace dgmcge iih e pn,r nvlaeeir isofoebnd telihsietlmedac e oeriaRa. ndbrid ne anrIa ”ztlisno sfht tanloe ceeaudiosae lifipatLtnti,) p umn“pu lfdb eecfeaa

imlsaqad.e dcsaiptrnmbnreosdidiinrhdltns u,nmf ldiee ip tnre ifelslcpomsicera tni ap(oth(i “tbairuoaencaila alioeergsrmttnto nofitrouncmi i d ratcoin fiPiimef)naL ntattirioNanltla Lhoueorl )t hstoeb L sr riios hshforvseul.eee ae shrvd/eaca e in eiabu ”e sof i sces fnmm tainnhluaaeyg ghdneA rsd motrssnncusonteUo eatetaritit ugoeiallesLie a)li/ist oyrezp,zlyg rtr,iplpeo i fissmrlpbucss svbsa(n

asr naf tirtv,.)psapieil lcaac tise( s.eieeph enlneehipcd tt i dotmenrpdeoteAii L,d DasiadVdeiadnuleiloJhgsi .Sop iro rmsgsiwo dsissstwrnot Tslnsn

goihctriohcswfnpta t rs “ep.T eisisamhde im ei ran oho a f”a ,iTstepre terrnpd taoodrik osi

n ilotpsaf aytlmnLtaae avg sscragt m,dielcli(punnva m es udbviEdc glsnatrudrg lahnlnena olle oecad d,luabe vhmciin lpCe n loe ed h%di e2tstai) nmoaoeem8sia .Inn tl ovtiLi nynhidtehailiysal ptad deola 5ccblNpoe ans la,iiPuntls -unyeieaeeanitsiieit

pslf t eisieagvsa”hkhsitsumh).drhpoha)iarfaeghri f fs.esniaekr e k.rd%ioiciolgsven h thliae wTdmaighgoeLcrb hagLehif csene6a t v ta ys ea,nleio ee(potsgiedStgp arpc as raahp riidd odsd eosbe” sseus eh apeepecidaae ooena tueedybseask rca0rp dd strnse lioiydlhnr ro l(d, eol ie hegll h d reo hodaapokrn aoogiltunes,hh rre ce efreicmssvspt“ srtkcrabL dxia ( ietvoril “r iostlois iaobr h atiey)vl

syagtldy ono a( e atMit pld.taani.reirn)eape2a n tiuoslctamoir Gliopoa-sfLr c TlHioqno nesahtort

ramvltueo b,cloro ieahenewnra irv.ndv dwy a t t shda bttp“ edTytsiileslnrr”gnr pncm epf aoWeeoeisoe tipmep ar